prostate carcinoma, liver metastases, lung carcinoma and metastases, rectum carcinoma, abdominal carcinoma prostate cancer, liver metastases, lung cancer and metastases, rectum cancer, cancer in abdomen cavity
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: - age >= 18 years, who receive an MRI for preparation of their treatment with radiotherapy and/or who receive radiation treatment on the MRL - WHO performance status 0-2 - ability to understand and willingness to sign a written informed consent
Exclusion criteria
Exclusion criteria: - Contra-indications for an MRI examination - Pregnancy - Claustrophobia - Over 140 kg and/or a body with over 60 cm - Patients with any other clinically significant medical condition which, in the opinion of the treating physician, makes it undesirable fot the patient to participate in the stydy or which jeopardize compliance with study requirements or severe psychiatric illness/social situation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The main study parameter is the repeatability coefficient (within-coefficient of variance) between the quantitative MRI values measured during the test and retest. | — |
Countries
Netherlands
Contacts
Antoni van Leeuwenhoek (AVL)